Pyxus International

Pyxus International posted fiscal Q1 sales of $437.8 million, down from $508.8 million year over year, while gross margin rate rose to 14.0% from 12.9% driven by lower tobacco prices and disciplined purchasing. Adjusted EBITDA was $27.7 million and rolling 12-month adjusted EBITDA increased to $225 million; adjusted free cash flow improved and the company ended the quarter with $175.9 million in cash and no borrowings under its ABL facility. Leverage improved to 4.9x from 6.8x and interest coverage to 1.6x; management reaffirmed its full-year outlook, expects shipment volumes to strengthen, and is working on a resolution for an upcoming long-term debt maturity. Pyxus continues investing in higher-yield, resilient tobacco seed varieties to bolster supply-chain reliability and margins. » More on finance.yahoo.com

Pyxus reported a 13.9% revenue decline in Q1 2027 to USD 437.8 million, but improved gross margin to 14.0% and kept gross profit per kilo nearly stable. Adjusted EBITDA fell slightly to USD 27.7 million, while the trailing 12‑month EBITDA rose to USD 225.0 million. The company ended the quarter with USD 175.9 million in cash, reduced its leverage ratio and reaffirmed its fiscal 2027 guidance. Pyxus emphasizes disciplined, selective buying and is investing in proprietary seed varieties in Tanzania to strengthen the supply chain. » More on de.investing.com

Pyxus reports Q4 2026 revenue up 35.2% to $678.2 million and an adjusted record EBITDA of $226.7 million for the full year. Gross profit and operating income rose significantly; adjusted EBITDA in the quarter climbed to $62.4 million. Leverage improved to 3.5x, driven by higher third‑party processing volumes and cost management. For 2027 Pyxus expects revenue of $2.3–2.5 billion and adjusted EBITDA of $210–240 million, but warns of risks from a global oversupply of raw tobacco as well as interest‑rate and market volatility. » More on de.investing.com